news
First US state bans ‘pay-for-delay’ pharma practice
California’s state governor has signed a bill which will stop drug makers from paying generic drug producers to stay off the market.
List view / Grid view
Drug Markets
article
Will the US pass a bill to lower drug prices?
Despite plans to lower drug prices in the US, political divisions have muddied the waters. This article examines the efforts made by those involved and the possibilities of their success.
news
CDMO outsourcing market to reach $36.51bn by 2023
The global pharma contract development and manufacturing organisation (CDMO) outsourcing market is predicted to grow.
news
CMA accuses three pharma companies of illegal market agreement
The UK Competition and Markets Authority has alleged that Aspen paid two other pharmaceutical companies to ensure they were the only supplier of a drug to the NHS.
news
UK government introduces trade restrictions to reduce drug shortages
The government has announced new measures to prevent parallel exporting to ease the supply chain, in an effort to reduce medicine shortages.
news
Survey finds shortages in all medicine categories in UK pharmacies
A survey of pharmacists has discovered that UK pharmacies experienced shortages across all 36 medicine categories in the last six months.
news
UK audit body finds no-deal Brexit drug supply preparation lacking
The UK National Audit Office has released a report which has found that medicine supply to the UK will be delayed in the event of a no-deal Brexit.
news
Boost needed for innovation in Indian pharma, study finds
Research has found that the pharmaceutical industry in India must encourage innovation in order to keep up with the growth of the sector.
article
How will technology aid an ageing world?
This article explores the potential of readily available technology to address current traceability challenges as well as more wide-ranging issues in the pharmaceutical industry.
news
Erenumab migraine drug fails to meet NICE recommendation standards
NICE has announced that it will not be recommending erenumab, an injectable migraine treatment, due to issues with cost and its long-term effectiveness.
news
Global injectable drug delivery market predicted to grow 12.8 percent
Increasing demand for convenient drug delivery, as well as an increase in diseases such as diabetes, has fuelled the global injectable drug delivery market.
news
Two drug firms admit to colluding to keep prices up
King Pharmaceuticals Limited and Alissa Healthcare Research Limited have admitted to sharing information to keep drug prices up.
news
EMA CHMP recommends seven medicines for approval
The EMA has suggested seven treatments to be granted marketing authorisations and also advocated indication extension for eight drugs.
news
Partnership between the BP and USP to be formalised
The British Pharmacopoeia and United States Pharmacopeia partnership is to be formalised to strengthen the quality of medicines and public health.
news
Treatment for dialysis patients with CKD anaemia approved in Japan
A treatment for anaemia associated with chronic kidney disease in dialysis patients has been approved in Japan.
